Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (191-200 of 721) with videos related to

Pageof 73
Sort By:
Annals of Medicine|October 30, 2015
Activation of brown adipose tissue in hypothyroidismConstantin Lapa, Yoshifumi Maya, Martin Wagner, et al.
Oncotarget|March 9, 2018
<sup>18</sup>F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancerHinrich Wieder, Ambros J Beer, Jens Siveke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2015
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available dataStefano Fanti, Silvia Minozzi, Paolo Castellucci, et al.
Nuclear Medicine Communications|August 30, 2014
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?Rudolf A Werner, Christina Bluemel, Constantin Lapa, et al.
Cancers|May 16, 2023
A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer PatientsFrancesca Serani, Wolfgang P Fendler, Paolo Castellucci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Efficacy of [<sup>18</sup>F]PSMA-1007 PET/CT in Primary Staging of Prostate Carcinoma: A Systematic Review and MetaanalysisKambiz Rahbar, Frederik L Giesel, Ken Herrmann, et al.
European Urology Focus|January 23, 2021
Prostate-specific Membrane Antigen-based Imaging of Castration-resistant Prostate CancerManuel Weber, Boris Hadaschik, Justin Ferdinandus, et al.
Molecular Pharmaceutics|June 29, 2026
Done EAZY: An Automated Procedure for <sup>89</sup>Zr-Radiolabeling and Size-Exclusion Chromatography Purification of Nanoliposomal Anticancer TherapeuticsJustin Dubbert, Falk Kunkel, Thomas Mühlenberg, et al.
Oncology Research and Treatment|June 8, 2021
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsRobert Seifert, Alina Küper, Mitra Tewes, et al.
Oncotarget|October 4, 2014
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationConstantin Lapa, Katharina Lückerath, Uwe Malzahn, et al.
Pageof 73

Showing results (191-200 of 721) with videos related to

Sort By:
Pageof 73
Annals of Medicine|October 30, 2015
Activation of brown adipose tissue in hypothyroidismConstantin Lapa, Yoshifumi Maya, Martin Wagner, et al.
Oncotarget|March 9, 2018
<sup>18</sup>F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancerHinrich Wieder, Ambros J Beer, Jens Siveke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2015
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available dataStefano Fanti, Silvia Minozzi, Paolo Castellucci, et al.
Nuclear Medicine Communications|August 30, 2014
Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?Rudolf A Werner, Christina Bluemel, Constantin Lapa, et al.
Cancers|May 16, 2023
A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer PatientsFrancesca Serani, Wolfgang P Fendler, Paolo Castellucci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 23, 2025
Efficacy of [<sup>18</sup>F]PSMA-1007 PET/CT in Primary Staging of Prostate Carcinoma: A Systematic Review and MetaanalysisKambiz Rahbar, Frederik L Giesel, Ken Herrmann, et al.
European Urology Focus|January 23, 2021
Prostate-specific Membrane Antigen-based Imaging of Castration-resistant Prostate CancerManuel Weber, Boris Hadaschik, Justin Ferdinandus, et al.
Molecular Pharmaceutics|June 29, 2026
Done EAZY: An Automated Procedure for <sup>89</sup>Zr-Radiolabeling and Size-Exclusion Chromatography Purification of Nanoliposomal Anticancer TherapeuticsJustin Dubbert, Falk Kunkel, Thomas Mühlenberg, et al.
Oncology Research and Treatment|June 8, 2021
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsRobert Seifert, Alina Küper, Mitra Tewes, et al.
Oncotarget|October 4, 2014
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationConstantin Lapa, Katharina Lückerath, Uwe Malzahn, et al.
Pageof 73